WEBSITE BSE:539334 NSE: SHREEPUSHK Inc. Year: 1993 Industry: Dyes & Pigments
Last updated: 15:56
Shree Pushkar Chemicals & Fertilisers Ltd is an totally India-based business enterprise, which is engaged within the enterprise of manufacturing and trading of chemical compounds, dyes and dyes intermediate, cattle feeds, fertilizers and soil conditioner. The Company's dye merchandise consist of acid dyes, direct dyes and reactive dyes below product names, inclusive of Leather Brown GG, Brown GR, Red F3B, Fast Red 46, Yellow GR and Yellow FG. Its cattle feed dietary supplements encompass Pushp Ahaar and Di Calcium Phosphate (DCP). Its fertilize...Read More
Shree Pushkar Chemicals & Fertilisers Ltd is an totally India-based business enterprise, which is engaged within the enterprise of manufacturing and trading of chemical compounds, dyes and dyes intermediate, cattle feeds, fertilizers and soil conditioner. The Company's dye merchandise consist of acid dyes, direct dyes and reactive dyes below product names, inclusive of Leather Brown GG, Brown GR, Red F3B, Fast Red 46, Yellow GR and Yellow FG. Its cattle feed dietary supplements encompass Pushp Ahaar and Di Calcium Phosphate (DCP). Its fertilizers department gives products, consisting of SSP, SC, NPK and SOP. It additionally offers Dharti Ratna, a soil conditioner primarily based on Gypsum. Its acids department includes Sulphuric 98%, Oleum 23%, Oleum 65% and Chloro Sulphonic acid. The Company's production centres provide a number of chemical reactions, which include sulfonation, nitration, acetylation, reduction, condensation, isolation, hydrolysis, amination, fusion and acetylation. The Company is targeted on Toll Manufacturing. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1099 Cr.
Stock P/E 18.8
P/B 1.9
Current Price ₹340
Book Value ₹ 178.8
Face Value 10
52W High ₹476.6
Dividend Yield 0.59%
52W Low ₹ 221.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 176 | 185 | 175 | 191 | 194 | 176 | 217 | 219 | 255 | 255 |
| Other Income | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 3 |
| Total Income | 177 | 188 | 178 | 193 | 198 | 178 | 219 | 222 | 258 | 258 |
| Total Expenditure | 162 | 171 | 161 | 172 | 177 | 157 | 195 | 195 | 225 | 229 |
| Operating Profit | 16 | 17 | 17 | 21 | 21 | 22 | 24 | 27 | 33 | 30 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| Depreciation | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 11 | 11 | 16 | 15 | 16 | 18 | 20 | 26 | 22 |
| Provision for Tax | 2 | 3 | 4 | 3 | 2 | 3 | 2 | 4 | 5 | 4 |
| Profit After Tax | 8 | 8 | 8 | 13 | 13 | 13 | 16 | 17 | 21 | 18 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 |
| Profit After Adjustments | 8 | 8 | 8 | 13 | 13 | 13 | 16 | 17 | 21 | 18 |
| Adjusted Earnings Per Share | 2.5 | 2.7 | 2.4 | 4.1 | 4.1 | 4.1 | 4.9 | 5.1 | 6.5 | 5.6 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 306 | 395 | 452 | 346 | 355 | 584 | 684 | 726 | 806 | 946 |
| Other Income | 2 | 2 | 3 | 4 | 7 | 7 | 8 | 11 | 11 | 11 |
| Total Income | 308 | 397 | 455 | 351 | 362 | 591 | 692 | 737 | 817 | 957 |
| Total Expenditure | 254 | 334 | 385 | 297 | 312 | 505 | 616 | 666 | 722 | 844 |
| Operating Profit | 54 | 63 | 70 | 54 | 50 | 87 | 76 | 71 | 95 | 114 |
| Interest | 3 | 3 | 4 | 2 | 1 | 2 | 2 | 2 | 2 | 5 |
| Depreciation | 5 | 8 | 10 | 11 | 13 | 14 | 19 | 22 | 23 | 24 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 46 | 52 | 56 | 40 | 36 | 71 | 56 | 48 | 70 | 86 |
| Provision for Tax | 16 | 16 | 15 | 4 | 7 | 15 | 18 | 11 | 11 | 15 |
| Profit After Tax | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 | 59 | 72 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 30 | 37 | 41 | 36 | 29 | 56 | 37 | 37 | 59 | 72 |
| Adjusted Earnings Per Share | 10 | 12.1 | 13.3 | 11.6 | 9.3 | 18 | 11.8 | 11.7 | 18.1 | 22.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 11% | 11% | 18% | 0% |
| Operating Profit CAGR | 34% | 3% | 12% | 0% |
| PAT CAGR | 59% | 2% | 10% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 19% | 26% | 22% | 11% |
| ROE Average | 12% | 10% | 11% | 13% |
| ROCE Average | 12% | 11% | 12% | 15% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 193 | 237 | 284 | 306 | 339 | 396 | 438 | 474 | 539 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 3 | 7 | 4 | 8 | 8 | 2 | 0 | 0 |
| Other Non-Current Liabilities | 11 | 14 | 21 | 19 | 23 | 30 | 36 | 40 | 45 |
| Total Current Liabilities | 55 | 137 | 114 | 114 | 119 | 204 | 188 | 201 | 293 |
| Total Liabilities | 260 | 391 | 426 | 444 | 489 | 637 | 664 | 715 | 877 |
| Fixed Assets | 123 | 166 | 172 | 164 | 175 | 195 | 313 | 295 | 308 |
| Other Non-Current Assets | 14 | 14 | 24 | 119 | 154 | 132 | 12 | 62 | 86 |
| Total Current Assets | 123 | 211 | 230 | 161 | 161 | 310 | 339 | 357 | 483 |
| Total Assets | 260 | 391 | 426 | 444 | 489 | 637 | 664 | 715 | 877 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 1 | 1 | 3 | 13 | 4 | 0 |
| Cash Flow from Operating Activities | 17 | -5 | 56 | 76 | 41 | 42 | 50 | 16 | 38 |
| Cash Flow from Investing Activities | -12 | -50 | -40 | -61 | -33 | -63 | -38 | -58 | -35 |
| Cash Flow from Financing Activities | -5 | 55 | -15 | -14 | -7 | 31 | -22 | 38 | -0 |
| Net Cash Inflow / Outflow | 0 | -0 | 0 | 0 | 2 | 10 | -9 | -3 | 2 |
| Closing Cash & Cash Equivalent | 0 | 0 | 1 | 1 | 3 | 13 | 4 | 0 | 3 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10 | 12.09 | 13.29 | 11.58 | 9.25 | 18.01 | 11.77 | 11.72 | 18.13 |
| CEPS(Rs) | 11.82 | 14.67 | 16.54 | 15.3 | 13.36 | 22.6 | 17.63 | 18.55 | 25.13 |
| DPS(Rs) | 1.5 | 0 | 1.5 | 0.5 | 1 | 2 | 1.5 | 1.5 | 2 |
| Book NAV/Share(Rs) | 63.86 | 74.15 | 89.71 | 99.3 | 109.93 | 127.05 | 138.37 | 148.56 | 166.64 |
| Core EBITDA Margin(%) | 16.95 | 15.45 | 14.79 | 14.24 | 12.18 | 13.61 | 10 | 8.34 | 10.41 |
| EBIT Margin(%) | 15.87 | 13.93 | 13.18 | 12.16 | 10.51 | 12.45 | 8.45 | 6.86 | 8.93 |
| Pre Tax Margin(%) | 15.04 | 13.21 | 12.36 | 11.55 | 10.1 | 12.12 | 8.13 | 6.64 | 8.65 |
| PAT Margin (%) | 9.88 | 9.25 | 9.04 | 10.31 | 8.04 | 9.51 | 5.44 | 5.1 | 7.27 |
| Cash Profit Margin (%) | 11.67 | 11.22 | 11.24 | 13.62 | 11.6 | 11.93 | 8.15 | 8.08 | 10.08 |
| ROA(%) | 11.63 | 11.23 | 10 | 8.21 | 6.12 | 9.86 | 5.72 | 5.38 | 7.37 |
| ROE(%) | 15.66 | 17.53 | 16.35 | 12.28 | 8.85 | 15.2 | 8.98 | 8.17 | 11.62 |
| ROCE(%) | 23.33 | 21.59 | 18.8 | 12.23 | 9.9 | 16.47 | 11.65 | 9.16 | 11.81 |
| Receivable days | 72.8 | 67.86 | 74.41 | 92.21 | 78.99 | 53.61 | 59.38 | 72.05 | 75.37 |
| Inventory Days | 37.97 | 52.69 | 58.39 | 65.54 | 60.37 | 45.94 | 46.52 | 36.59 | 50.51 |
| Payable days | 38.62 | 49.07 | 57.5 | 83.55 | 88.59 | 68.85 | 76.7 | 64.37 | 82.8 |
| PER(x) | 20.04 | 16.77 | 12.38 | 6.38 | 14.77 | 15.52 | 12.56 | 13.59 | 14.7 |
| Price/Book(x) | 3.14 | 2.74 | 1.83 | 0.74 | 1.24 | 2.2 | 1.07 | 1.07 | 1.6 |
| Dividend Yield(%) | 0.75 | 0 | 0.91 | 0.68 | 0.73 | 0.72 | 1.01 | 0.94 | 0.75 |
| EV/Net Sales(x) | 1.96 | 1.67 | 1.13 | 0.8 | 1.34 | 1.61 | 0.78 | 0.84 | 1.16 |
| EV/Core EBITDA(x) | 11.07 | 10.48 | 7.38 | 5.19 | 9.52 | 10.82 | 6.95 | 8.56 | 9.89 |
| Net Sales Growth(%) | 0 | 29.22 | 14.33 | -23.36 | 2.48 | 64.54 | 17.13 | 6.16 | 11.03 |
| EBIT Growth(%) | 0 | 13.49 | 8.12 | -29.27 | -11.43 | 94.93 | -20.52 | -13.83 | 44.61 |
| PAT Growth(%) | 0 | 20.95 | 11.76 | -12.57 | -20.09 | 94.65 | -32.97 | -0.46 | 58.16 |
| EPS Growth(%) | 0 | 20.95 | 9.92 | -12.89 | -20.09 | 94.65 | -34.64 | -0.46 | 54.68 |
| Debt/Equity(x) | 0.08 | 0.29 | 0.17 | 0.17 | 0.17 | 0.23 | 0.16 | 0.23 | 0.18 |
| Current Ratio(x) | 2.22 | 1.54 | 2.03 | 1.41 | 1.35 | 1.52 | 1.8 | 1.78 | 1.65 |
| Quick Ratio(x) | 1.65 | 0.94 | 1.48 | 0.87 | 0.89 | 1.07 | 1.36 | 1.47 | 1.1 |
| Interest Cover(x) | 19.13 | 19.26 | 16.03 | 19.78 | 25.7 | 37.1 | 26.11 | 31.88 | 31.48 |
| Total Debt/Mcap(x) | 0.02 | 0.11 | 0.09 | 0.23 | 0.14 | 0.11 | 0.15 | 0.21 | 0.12 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 68.6 | 68.6 | 68.6 | 68.6 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 | 69.36 |
| FII | 1.35 | 1.35 | 1.39 | 1.59 | 1.62 | 0.41 | 0.86 | 0.42 | 1.47 | 0.59 |
| DII | 1.04 | 0.75 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.38 |
| Public | 29 | 29.3 | 30.01 | 29.8 | 29.02 | 30.23 | 29.78 | 30.22 | 29.17 | 29.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.17 | 2.17 | 2.17 | 2.17 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 | 2.24 |
| FII | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.01 | 0.03 | 0.01 | 0.05 | 0.02 |
| DII | 0.03 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Public | 0.92 | 0.93 | 0.95 | 0.94 | 0.94 | 0.98 | 0.96 | 0.98 | 0.94 | 0.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.16 | 3.16 | 3.16 | 3.16 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 | 3.23 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.